GABA Therapeutics Sets Date for 2026 Annual Stockholder Meeting

The meeting agenda centers on electing directors to serve until their terms expire or successors are appointed, alongside any additional business brought before the session. Participation is restricted to stockholders of record as of the close of business on August 31, 2026. These eligible voters may cast their ballots via video conference, phone, or in person, as outlined in the company's formal notice.

In preparation for the event, GABA Therapeutics will maintain a full list of eligible stockholders at its principal executive offices. This document will remain available for examination by any stockholder for purposes related to the meeting during standard business hours for at least 10 days prior to the gathering. Richard G. Farrell, Secretary and Chief Financial Officer, emphasized the necessity of stockholder participation regardless of physical attendance.